High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.